Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of...
Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize the vaccine candidate for...
27.11.2019
- Israeli generics giant Teva Pharmaceuticals and other generic drugmakers have been discussing possible settlements with US federal prosecutors in a long-running price-fixing probe...
25.10.2019
- Another US opioid maker has moved to settle charges against it out of court. Reckitt Benckiser will pay $700 million to settle six states' claims that its former Indivior business...
22.10.2019
- After negotiating through the night, Israeli generics giant Teva – which is a leading supplier of the US market – and the three biggest US drug distributors on Oct. 21 reached a...
17.10.2019
- Long anticipated bundled proceedings against opioid manufacturers and US opioid distributors began on Oct. 16 in a US court in Cleveland, Ohio, where cases against Israeli generics...
10.09.2019
- Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...
